/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
Cumberland Pharmaceuticals declared a special cash dividend of $1.50 per share, payable on July 31, 2026, to shareholders of record as of July 23, 2026. The capital distribution follows the closing of a strategic transaction with Apotex Health, which provided $100 million in cash upfront and up to $11 million in additional expected payments.
Key figures
- Deal Value Usd
- 100000000
- Dividend Per Share
- 1.5
- Repurchase authorization
- 5000000
- Expected additional payments
- 11000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.